FOLATE RECEPTOR TARGETED NANOPARTICLE DRUG CONJUGATES AND USES THEREOF

Number of patents in Portfolio can not be more than 2000

United States of America Patent

APP PUB NO 20230263898A1
SERIAL NO

18183305

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The disclosure relates to nanoparticle drug conjugates (NDC) that comprise ultrasmall nanoparticles, folate receptor (FR) targeting ligands, and linker-drug conjugates, and methods of making and using them to treat cancer.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELUCIDA ONCOLOGY INC1 DEER PARK DRIVE SUITE E MONMOUTH JUNCTION NJ 08852

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
ADAMS, Gregory Paul Hatboro, US 4 4
CHEN, Feng Princeton, US 635 6497
GARDINIER,, II Thomas Courtney Raritan, US 5 6
GERMANO,, Jr Geno J Philadelphia, US 5 6
LEE, Francis YF Yardley, US 14 60
MA, Kai Montgomery, US 133 7232
TÜRKER, Melik Ziya Princeton, US 5 6
VENKATESAN, Aranapakam M Rego Park, US 57 453
WU, Fei Plainsboro, US 179 1254

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation